Zheng et al. demonstrated that CD4+ T cells with low levels of IFN‐γ, IL‐2 and TNF‐α were higher in severe COVID‐19 patients, compared with healthy controls and mild patients.90 The gene discussed is CD4; the disease is COVID-19.